Literature DB >> 29168298

Biallelic mutations in NALCN: Expanding the genotypic and phenotypic spectra of IHPRF1.

Toshiki Takenouchi1,2, Mie Inaba3, Tomoko Uehara1, Takao Takahashi2, Kenjiro Kosaki1, Seiji Mizuno3.   

Abstract

Loss-of function mutations in NALCN on chromosome 13q, a sodium leak channel that maintains baseline neuronal excitability, cause infantile hypotonia with psychomotor retardation and characteristic faces 1 (IHPRF1, OMIM #615419). Here, we document two individuals with early onset hypotonia with poor feeding and intellectual disability who were compatible with a diagnosis of IHPRF1. The two patients had bi-allelic mutations in NALCN through two different genetic mechanisms: Patient 1 had bi-allelic splice site mutations, that is c.1267-2A>G, derived from heterozygous parents, while Patient 2 had a partial maternal uniparental isodisomy that harbored a frameshift mutation, that is c.2022_2023delAT, in chromosome 13 that was detected through a dedicated algorithm for homozygosity data mapping in whole exome sequencing. The delineation of the exact pattern of inheritance provided vital information regarding the risk of recurrence. In animal models with Nalcn mutations, two behavioral phenotypes, that are, postnatal dyspnea and sleep disturbance, have been reported. Our observations of the two patients with postnatal dyspnea and one patient with sleep disturbance support an association between these two behavioral phenotypes and NALCN mutations in humans. The routine use of a detection algorithm for homozygosity data mapping might improve the diagnostic yields of next-generation sequencing.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  NALCN; chromosome 13; dyspnea; infantile hypotonia with psychomotor retardation and characteristic faces 1; intellectual disability; uniparental isodisomy

Mesh:

Substances:

Year:  2017        PMID: 29168298     DOI: 10.1002/ajmg.a.38543

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

Review 1.  Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson's disease.

Authors:  Merve Kasap; Donard S Dwyer
Journal:  J Neural Transm (Vienna)       Date:  2021-05-07       Impact factor: 3.575

2.  Genetic variants in components of the NALCN-UNC80-UNC79 ion channel complex cause a broad clinical phenotype (NALCN channelopathies).

Authors:  Nuria C Bramswig; Aida M Bertoli-Avella; Beate Albrecht; Aida I Al Aqeel; Amal Alhashem; Nouriya Al-Sannaa; Maissa Bah; Katharina Bröhl; Christel Depienne; Nathalie Dorison; Diane Doummar; Nadja Ehmke; Hasnaa M Elbendary; Svetlana Gorokhova; Delphine Héron; Denise Horn; Kiely James; Boris Keren; Alma Kuechler; Samira Ismail; Mahmoud Y Issa; Isabelle Marey; Michèle Mayer; Jennifer McEvoy-Venneri; Andre Megarbane; Cyril Mignot; Sarar Mohamed; Caroline Nava; Nicole Philip; Cecile Ravix; Arndt Rolfs; Abdelrahim Abdrabou Sadek; Lara Segebrecht; Valentina Stanley; Camille Trautman; Stephanie Valence; Laurent Villard; Thomas Wieland; Hartmut Engels; Tim M Strom; Maha S Zaki; Joseph G Gleeson; Hermann-Josef Lüdecke; Peter Bauer; Dagmar Wieczorek
Journal:  Hum Genet       Date:  2018-08-23       Impact factor: 4.132

3.  Periodic breathing in patients with NALCN mutations.

Authors:  Danielle K Bourque; David A Dyment; Ian MacLusky; Kristin D Kernohan; Hugh J McMillan
Journal:  J Hum Genet       Date:  2018-07-03       Impact factor: 3.172

4.  Intellectual disability-associated UNC80 mutations reveal inter-subunit interaction and dendritic function of the NALCN channel complex.

Authors:  Jinhong Wie; Apoorva Bharthur; Morgan Wolfgang; Vinodh Narayanan; Keri Ramsey; Kimberly Aranda; Qi Zhang; Yandong Zhou; Dejian Ren
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

5.  A Homozygous Truncating Mutation in NALCN Causing IHPRF1: Detailed Clinical Manifestations and a Review of Literature.

Authors:  Amir Hossein Karimi; Mohammad Reza Karimi; Poopak Farnia; Farshid Parvini; Majid Foroutan
Journal:  Appl Clin Genet       Date:  2020-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.